aldosterone has been researched along with finasteride in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellavance, E; Luu-The, V; Poirier, D | 1 |
Altuğ, U; Arik, AI; Erol, D; Uygur, MC | 1 |
1 trial(s) available for aldosterone and finasteride
Article | Year |
---|---|
Effects of the 5 alpha-reductase inhibitor finasteride on serum levels of gonadal, adrenal, and hypophyseal hormones and its clinical significance: a prospective clinical study.
Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Aldosterone; Androgens; Dehydroepiandrosterone; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Hydrocortisone; Luteinizing Hormone; Male; Middle Aged; Pregnenediones; Prospective Studies; Prostatic Hyperplasia; Testosterone | 1998 |
1 other study(ies) available for aldosterone and finasteride
Article | Year |
---|---|
Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Topics: 17-Hydroxysteroid Dehydrogenases; Androstane-3,17-diol; Androstanes; Biocatalysis; Cell Line; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Humans; Inhibitory Concentration 50; Oxidation-Reduction; Substrate Specificity | 2009 |